Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  WIENER BOERSE AG  >  Sanochemia Pharmazeutika AG    SCPH   AT0000776307

SANOCHEMIA PHARMAZEUTIKA AG (SCPH)
Mes dernières consult.
Most popular
  Report  
End-of-day quote. End-of-day quote  - 07/13
1.8 EUR   +1.12%
05/07SANOCHEMIA PHAR : Ad hoc Information
PU
01/25SANOCHEMIA PHAR : Ad hoc Information
PU
2017SANOCHEMIA PHAR : Successful Phase I Study Results
PU
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Wiener Boerse Ag
07/05/2018 07/09/2018 07/10/2018 07/11/2018 07/13/2018 Date
1.77 1.71 1.7 1.78 1.8 Last
2500 4000 4322 1226 7853 Volume
+3.51% -3.39% -0.58% +4.71% +1.12% Change
Financials (EUR)
Sales 2017 49,2 M
EBIT 2017 1,30 M
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 46,5 M
EBIT 2018 1,80 M
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0,47x
Capi. / Sales2018 0,50x
Capitalization 23,2 M
More Financials
Company
SANOCHEMIA Pharmazeutika AG engages in the manufacture and distribution of pharmaceutical products.It operates through the following segments: Production, Human Pharmaceuticals, Veterinary Pharmaceuticals, and Research and Development.The Production segment focuses on synthesis of active... 
Sector
Pharmaceuticals
Calendar
09/05Earnings Release
More about the company
Latest news on SANOCHEMIA PHARMAZEUTIKA A
05/07SANOCHEMIA PHARMAZEUTIKA : Ad hoc Information
PU
01/25SANOCHEMIA PHARMAZEUTIKA : Ad hoc Information
PU
2017SANOCHEMIA PHARMAZEUTIKA : Successful Phase I Study Results
PU
2017SANOCHEMIA PHARMAZEUTIKA : Tolperisone USA
PU
2017SANOCHEMIA PHARMAZEUTIKA : Advantage of tolperisone in comparison to another mus..
PU
2017SANOCHEMIA PHARMAZEUTIKA : Notice of Allowance for Tolperisone in the US
PU
2017SANOCHEMIA PHARMAZEUTIKA AG : half-yearly earnings release
2017SANOCHEMIA PHARMAZEUTIKA : Participation at the ECR
PU
2017SANOCHEMIA PHARMAZEUTIKA : Advancement of Tolperisone's Clinical Development in ..
PU
2017SANOCHEMIA PHARMAZEUTIKA : Grant of patent for Vidon® in the USA
PU
More news
Sector news : Specialty & Advanced Pharmaceuticals
07/14INDIVIOR : wins preliminary injunction against generic rival
RE
07/13TEVA PHARMACEUTICAL INDUSTRIES : FDA Recalls Several Medicines That Contain Vals..
DJ
07/13NOVARTIS : Played Down Ties to Trump Lawyer Michael Cohen, Report Says
DJ
07/13JOHNSON & JOHNSON : J&J vows to overturn $4.7 billion talc verdict but experts s..
RE
07/13NOVARTIS : disputes U.S. senators' report on Cohen contract
RE
More sector news : Specialty & Advanced Pharmaceuticals
Chart SANOCHEMIA PHARMAZEUTIKA A
Duration : Period :
Sanochemia Pharmazeutika A Technical Analysis Chart | SCPH | AT0000776307 | 4-Traders
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 3,00 €
Spread / Average Target 67%
Managers
NameTitle
Eveline Frantsits Chairman-Supervisory Board
Stefan Welzig Chief Financial & Technical Officer
Christina Abrahamsberg Chief Scientific Officer
Anton Dallos Member-Supervisory Board
Werner Josef Frantsits Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SANOCHEMIA PHARMAZEUTIKA AG20.00%27
ABBVIE-0.08%153 340
MERCK KGAA-4.60%12 930
KYOWA HAKKO KIRIN CO LTD-0.99%11 282
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD97.15%11 237
JAZZ PHARMACEUTICALS PLC30.69%10 609